Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Boehringer Ingelheim
Johnson and Johnson
Harvard Business School
Colorcon

Last Updated: July 5, 2020

DrugPatentWatch Database Preview

Patent: 9,216,206

» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,216,206
Title:Methods of treating symptoms associated with menopause and hormonal variations with G-CSF
Abstract: The invention provides for compositions and methods of treating or ameliorating menopausal symptoms and/or symptoms associated with hormonal variations by administering granulocyte colony-stimulating factor (G-CSF). The invention also provides for compositions and methods of treating or ameliorating arthritis using G-CSF.
Inventor(s): Duke; Debra M. (Denver, CO), Duke; Richard C. (Denver, CO)
Assignee: MenoGeniX, Inc. (Aurora, CO)
Application Number:13/055,368
Patent Claims:see list of patent claims

Details for Patent 9,216,206

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Amgen NEULASTA pegfilgrastim SYRINGE 125031 001 2002-01-31   Start Trial MenoGeniX, Inc. (Aurora, CO) 2028-07-22 RX Orphan search
Amgen NEUPOGEN filgrastim SYRINGE 103353 004 1991-02-20   Start Trial MenoGeniX, Inc. (Aurora, CO) 2028-07-22 RX search
Amgen NEUPOGEN filgrastim SYRINGE 103353 003 1991-02-20   Start Trial MenoGeniX, Inc. (Aurora, CO) 2028-07-22 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 002 1991-02-20   Start Trial MenoGeniX, Inc. (Aurora, CO) 2028-07-22 RX search
Amgen NEUPOGEN filgrastim VIAL 103353 001 1991-02-20   Start Trial MenoGeniX, Inc. (Aurora, CO) 2028-07-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Moodys
Dow
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.